Dichloroacetate (DCA) in Patients With Previously Treated Metastatic Breast or Non-Small Cell Lung Cancer (NSCL)
Stopped DSMB determined, due to higher than expected risk/safety concerns, study should be closed.
Conditions
- Metastatic Breast Cancer
- Lung Cancer
Interventions
- DRUG: Dichloroacetate (DCA)
Sponsor
Jonsson Comprehensive Cancer Center